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Abstract
Background: Mortality dramatically rises with the onset of symptoms in patients with 
severe aortic stenosis (AS). Surgery is indicated when symptoms become apparent or 
when there is ventricular decompensation. Cardiopulmonary exercise testing (CPET) in 
combination with exercise echocardiography can unmask symptoms and provides valuable 
information regarding contractile reserve. The aim of the present study was to determine 
the prevalence of reduced exercise tolerance and the parameters predicting adverse 
cardiovascular events.
Methods: Thirty-two patients with asymptomatic severe AS were included in this study. 
Patients were followed up as part of an enhanced surveillance clinic.
Results: Age was 69 ± 15.7 years, 75% of patients were male. Patients had a raised 
NT-ProBNP of 301 pg/mL. VO2peak was 19.5 ± 6.2 mL/kg/min. Forty-one percent of patients 
had a reduced %VO2peak and this predicted unplanned cardiac hospitalisation (P = 0.005). 
Exercise systolic longitudinal velocity (S′) and age were the strongest independent 
predictors for VO2peak (R2 = 0.76; P < 0.0001). Exercise S′ was the strongest independent 
predictor for NT-ProBNP (R2 = 0.48; P = 0.001).
Conclusion: A large proportion of patients had a lower than predicted VO2peak. The major 
determinant of exercise and NT-ProBNP is the ability of the left ventricle (LV) to augment 
S′ on exercise rather than the severity of aortic valve obstruction or resting structural 
remodelling of the LV. Reduced exercise tolerance and more adverse remodelling, rather 
than valve obstruction predicted unplanned hospitalisation. This study demonstrates that 
for those patients, in whom a watchful waiting is an agreed strategy, a detailed assessment 
should be undertaken including CPET, exercise echocardiography and biomarkers to ensure 
those with exercise limitation and risk of decompensation are detected early and treated 
appropriately.
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Introduction
Aortic stenosis (AS) results in obstruction of blood flow 
through the aortic valve. The ventricular response to 
chronic pressure overload and other consequences of AS 
such as subtle myocardial ischaemia (1) are also important 
to understand. The natural history of AS is characterised 
by an extended latent period which can last between 10 
and 20  years. While patients are asymptomatic during 
this period, it is accepted that prognosis is excellent; 
however, mortality rises dramatically from the onset of 
cardiac symptoms (breathlessness, syncope, angina), 
approximately 25% at 1 year and 50% at 2 years (2, 3). 
Consequently current guidelines suggest that aortic 
valve intervention is indicated when patients become 
symptomatic or if there is echocardiographic evidence 
of imminent ventricular decompensation (4). A delay to 
surgery may result in a decrease in myocardial performance, 
increasing myocardial fibrosis and remodelling which does 
not fully recover following surgery, and this is associated 
with a significant increase in late morbidity and mortality 
(5, 6). Determining why and when patients develop 
symptoms is not always straightforward especially in an 
elderly population. Around one-third of ‘asymptomatic 
patients’ actually develop cardiac symptoms on exertion 
(7). Cardiopulmonary exercise testing (CPET) is an 
objective assessment of patients’ exercise tolerance and 
therefore can assist in unmasking any symptoms (8, 9). 
Studies have previously reported that over half of the 
included patients with ‘asymptomatic’ severe AS have 
a reduced VO2peak implying that a large proportion of 
self-reported asymptomatic patients are actually limited 
by symptoms (10, 11). The aims of the study were firstly 
to determine the level of reduced exercise tolerance in 
a cohort of patients with severe ‘asymptomatic’ AS and 
secondly to determine if exercise tolerance in these 
symptom-free patients was defined by obstruction to the 
aortic valve, ventricular remodelling or left ventricular 
contractile reserve. Thirdly the study aimed to determine 
which aforementioned parameter best predicted future 
events during clinical follow-up.
Methods
This was a retrospective longitudinal study of 32 patients 
with severe AS. Patients were followed up as part of 
an enhanced surveillance clinic which includes CPET 
combined with exercise echocardiography and N-terminal 
pro-type natriuretic peptide (NT-ProBNP) measurements. 
Patients who subjectively reported to be asymptomatic 
were referred into the clinic. All patients had a calculated 
aortic valve area (AVA) of less than 1.0 cm2, a peak aortic 
velocity (Vmax) of more than 4.0 m/sec or a mean aortic 
pressure gradient (mean PG) greater than 40 mmHg. 
Patients had a left ventricular ejection fraction (LVEF) 
above 55% and were able to perform CPET testing. 
Exclusion criteria included self-reported symptoms 
associated AS, co-morbidities affecting symptoms, a 
positive test for reversible ischaemia, unable to exercise 
or poor echocardiographic windows. Excluded patients 
who were unable to perform exercise were followed up 
with regular resting transthoracic echocardiograms and 
symptom assessment.
Echocardiography
Echocardiography was performed using a GE Vivid 9 
platform (Vingmed-General Electric, Horten, Norway) 
equipped with a phased-array 3.5 MHz transducer. All 
measurements were made according to the guidelines set 
by the British Society of Echocardiography (12). At rest, 
the left ventricular outflow tract (LVOT) diameter and 
ventricular internal dimensions were measured in zoom 
mode from the parasternal long axis view, measurements 
were taken at the level of the mitral valve tips. A protocol 
was created and the following views were obtained 
both at rest and at peak exercise. The 2D apical views 
(4-chamber, 2-chamber, and apical long axis view), a 
4-chamber view with tissue velocity imaging (TVI) turned 
on in the background. Continuous wave and pulse wave 
Doppler through the aortic valve. The mean PG was 
measured using the modified Bernouilli equation. AVA 
was calculated using the continuity equation. LV volumes 
and LVEF were calculated using Simpson’s biplane 
method in the apical four-chamber and two-chamber 
views. Q-analysis was used retrospectively to determine 
the longitudinal systolic velocity (S′) where the sample 
volume was placed at the septal and lateral part of the 
mitral annulus. Rest and exercise S′ (defined as the highest 
velocity during systole after the end of isovolumetric 
contraction) was obtained from the lateral and septal 
annulus and averaged at rest and exercise. The relative 
wall thickness (RWT) was calculated by multiplying the 
posterior wall thickness by two and dividing this by the 
LV end diastolic diameter. A value greater than 0.42 is 
suggestive of concentric hypertrophy and a value below 
0.42 of eccentric hypertrophy (13). Images were obtained 
in real time and analysed after each study. Images were 
stored offline.
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Cardiopulmonary exercise test
A semi-recumbent tilting cycle ergometer (ERG 911 
S/L, Schiller, Baar, Switzerland) was used. At the start of 
the test a 1-min rest period was included followed by a 
3-min unloaded warm up period. Exercise protocols were 
individually determined based on the patient functional 
status. Work rate (5, 10, 15 or 20 Watt) increased every 
minute until voluntary exhaustion aiming for 8–10 min of 
exercise. Patients were asked to continue their medication 
as usual. Heart rate (HR), blood pressure and oxygen 
saturation were monitored throughout. Oxygen uptake 
(VO2), carbon dioxide production (VCO2) and ventilation 
(VE) were continuously measured and derived using a 
calibrated breath-by-breath analyser (Quark, Cosmed, 
Italy). A respiratory exchange ratio (RER) >1 was used to 
indicate a good effort. Echocardiography measurements 
commenced when patients were close to finishing the test 
when the RER was exceeding 0.95 and if patients were 
not taking beta blockers in combination with a peak 
predicted HR greater than 85% of age predicted maximum. 
Echocardiographic measurements were taken within 90 s 
of finishing exercise. Patients were verbally encouraged to 
exercise until maximal exertion. All tests were performed 
according to the exercise testing guidelines (14). VO2peak 
was expressed as the highest value from an average of 
30 s during the final stage of the exercise test. A predicted 
VO2 of less than 84% was considered to be reduced. The 
oxygen uptake efficiency slope (OUES) is the slope of VO2 
against the logarithm of VE (logVE) (15). The VE/VCO2 
slope was measured using the whole slope as a marker of 
the effectiveness of ventilation/perfusion matching.
NT-ProBNP
Blood analysis was performed at rest prior to the 
appointment. The Roche Elecsys NT-ProBNP assay was 
used on a Roche Modular E170 immunoassay platform. 
Serum was collected using standard sampling tubes 
containing separating gel. Samples were centrifuged. 
NT-proBNP measurements were carried out using an ELISA 
technique using two monoclonal antibodies in a sandwich 
technique and streptavidin-coated microparticles.
Follow-up
CPET combined with exercise echocardiography and 
the NT-ProBNP measurements were performed during 
all visits. A consultant cardiologist specialist in cardiac 
imaging and valve disease determined patients’ follow-up. 
Data used for the exercise predictive model was the last 
visit prior aortic valve intervention or the last available 
follow-up appointment. Data used for cardiac events 
model were taken from the first test after referral to the 
clinic. Cardiac admissions (unplanned cardiac admission 
lasting more than 24 h) and aortic valve replacement 
were based on detailed analysis of hospital case notes and 
electronic records.
Statistical analyses
Normality of data was tested with the Kolmogorov–
Smirnov test. Continuous variables were expressed 
as mean ± standard deviation (s.d.) or as a median 
(interquartile range (IQR)). Categorical data are 
presented as absolute values and percentages. Pearson or 
Spearman correlation coefficients were used to determine 
correlations between VO2peak or NT-ProBNP and 
clinical, demographic and echocardiographic parameters. 
Potential predictors for VO2peak or NT-ProBNP were 
entered in a multivariate linear regression model. Student 
T-tests were used to determine the differences between 
patients who were hospitalised versus those that were not. 
Event rates were estimated using Kaplan–Meier curves 
and compared using a log-rank test. Receiver-operating 
characteristics (ROC) curves were used to determine the 
optimal prognostic threshold value (highest combination 
of sensitivity/specificity) for hospitalisation. A P value of 
less than 0.05 was considered statistically significant. All 
statistical analyses were carried out using the Statistical 
Package for the Social Sciences (SPSS version 20.0; 
SPSS Inc).
Results
A total of 32 patients were included. The average 
follow-up time was 23 ± 15  months, ranging from 1 up 
to 64  months over a total of 57 visits. Sixteen patients 
were referred for aortic valve intervention with an 
average time to referral of 14 ± 8.8  months, ranging 
from 0 up to 32  months. Three quarter of the patients 
were male. All patients had a LVEF within normal 
range (Table  1). No patients died during follow-up. 
Median NT-ProBNP was 301 (IQR: 105–571) pg/mL. 
Average age was 68.8 ± 15.7 years.
Average VO2peak was 19.5 ± 6.2 mL/kg/min. Almost half 
of the patients (41%) had a reduced exercise tolerance based 
on a predicted VO2peak below 84%. Average OUES was 
1993 ± 636 (mL/min)/(L/min). In contrast to conventional 
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exercise parameters, no patient had a drop in blood 
pressure during exercise although three patients failed to 
augment their blood pressure. Four patients were short of 
breath disproportionate to the level of exercise. No patients 
suffered from chest pain or syncope during or post exercise.
Regarding the prediction of exercise performance, S′ 
obtained at peak exercise had the strongest correlation with 
VO2peak (rho = 0.61; P < 0.001) (Fig. 1), while augmentation 
of ejection fraction did not. A relationship was observed 
between conventional markers of AS obstruction and 
VO2peak; Vmax and mean PG at rest showed correlations 
of rho = 0.42 (P = 0.02) and rho = 0.40 (P = 0.02) respectively 
(Table 2). No relationship was found with stroke volume (SV), 
AVA or dimensionless velocity index. Resting parameters for 
systolic function (LVEF or S′ likewise did not correlate with 
VO2peak). A strong correlation was found with VO2peak and 
age (rho = −0.76; P < 0.0001 and height (rho = 0.45; P = 0.009) 
as expected. During exercise a similar weak association was 
found with the measures of aortic valve obstruction, Vmax 
(rho = 0.43, P = 0.02) and mean PG (rho = 0.43, P = 0.02) but 
again no correlation was observed for LVEF, SV or AVA 
during exercise and VO2peak (Table  2). In multivariate 
analysis, exercise S′ and age were the strongest independent 
predictors for VO2peak with a R2 for the model of 0.76 and a 
β-coefficient for exercise S′ of 1.004 (0.03–1.98); P = 0.04 and 
−0.29 (−0.41 to −0.18; P < 0.0001) for age.
A further predictive model for the log NT-ProBNP 
demonstrated a good relationship with exercise S′ (r = 0.75), 
but no relationship was observed for Vmax, mean PG or 
the AVA (Table 3). Multivariate analyses demonstrated 
that exercise S′ was the strongest predictor for NT-ProBNP 
with an R2 of 0.48 and a β-coefficient of −0.24 (−0.37 to 
−0.10); P = 0.001.
No patients died during follow-up; however, nine 
patients required unplanned cardiac admission. Patients 
who required cardiac admission had a lower percentage 
predicted VO2 (77 ± 15.5% vs 92 ± 18.0%; P = 0.03) and 
a greater RWT (0.49 ± 0.11 vs 0.40 ± 0.08; P = 0.02). 
VO2peak below 84% was a strong predictor for cardiac 
hospitalisation. A ROC analysis was performed for 
hospitalisation and % predicted VO2 had the largest area 
under the curve R2 = 0.76 (95% CI: 0.57–0.96). A cut-off 
of 84.5% for %predicted VO2 showed a sensitivity and 
specificity of 78 and 74% respectively (Fig. 2). A Kaplan–
Meier curve was generated using this cut-off (Fig.  3). 
A total of 16 patients were referred for aortic valve 
intervention during follow-up. No significant predictors 
were found for exercise S′ and hospitalisation. The only 
difference between those who were referred for surgery 
and those who continued with watchful waiting was a 
higher mean PG at rest (33.0 mmHg ± 7.2 vs 39.7 ± 10.3, 
P = 0.049 respectively).
Table 1 Demographics for all patients.
Parameter All patients (n = 32) VO2 peak < 84% predicted (n = 13) VO2 peak > 84% predicted (n = 19)
Age (years) 68.8 ± 15.7 63.5 ± 17.1 72.4 ± 14.0
Weight (kg) 79.3 ± 12.5 80.5 ± 10.3 78.6 ± 14.0
Height (m) 1.72 ± 0.08 1.74 ± 0.06 1.71 ± 0.09
Males (%) 24 (75%) 12 (92%) 12 (63%)
NT-proBNP (pg/mL) 301 (105–571) 155 (91–440) 302 (200–808)
Rest LVEF 62.8 ± 5.4 61.1 ± 4.2 63.8 ± 5.9
RWT 0.43 ± 0.1 0.48 ± 0.1 0.39 ± 0.08
Rest S′ (cm/s) 5.5 ± 1.14 5.3 ± 1.0 5.6 ± 1.2
Rest Vmax (cm/s) 4.00 ± 0.5 4.0 ± 0.4 4.0 ± 0.5
Rest mean PG (mmHg) 36.8 ± 9.4 35.3 ± 9.8 37.1 ± 9.3
SV rest (mL) 75.7 ± 17.0 72.0 ± 22.2 75.4 ± 14.0
SV exercise (mL) 80.8 ± 17.8 81.3 ± 23.8 80.5 ± 13.3
Rest AVA (cm2) 0.88 ± 0.2 0.89 ± 0.04 0.87 ± 0.04
Rest AVAi (cm2/m2) 0.47 ± 0.1 0.47 ± 0.03 0.46 ± 0.02
Exercise S′ 7.4 ± 1.8 7.2 ± 1.4 7.6 ± 2.1
Exercise Vmax 4.6 ± 0.5 4.6 ± 0.5 4.5 ± 0.6
Exercise mean PG 50.4 ± 13.6 49.8 ± 14.7 51.6 ± 12.0 
VO2 peak (mL/kg/min) 19.5 ± 6.2 18.9 ± 6.2 19.9 ± 6.3
OUES ((mL/min)/(L/min)) 1993 ± 636 1944 ± 470 2025 ± 736
VE/VCO2 slope 32.3 ± 5.3 32.4 ± 6.7 32.2 ± 4.2
O2 pulse peak 11.7 ± 3.03 11.4 ± 2.4 11.9 ± 3.4
HR peak (beats/min) 133 ± 26.5 131 ± 24.1 132 ± 21.0
Peak WR (watts) 105 ± 56.5 103 ± 51.5 107 ± 61.7
Peak RER 1.07 ± 0.12 1.09 ± 0.15 1.06 ± 0.09
This work is licensed under a Creative Commons 
Attribution-NonCommercial 4.0 International 
License.
https://erp.bioscientifica.com © 2019 The authors
 Published by Bioscientifica Ltdhttps://doi.org/10.1530/ERP-19-0005
Downloaded from Bioscientifica.com at 08/06/2019 08:59:40AM
via free access
J van Zalen et al. Contractile reserve in 
asymptomatic severe AS
476:3
Discussion
This study demonstrated that a large proportion of 
supposedly asymptomatic patients had a lower than 
predicted %VO2peak suggesting that patients have exercise 
intolerance, this is in agreement with previous reports in 
the literature (10, 11). In this study CPET identified a much 
higher proportion of symptomatic individuals than would 
have been identified if traditional parameters currently 
recommended in guideline documents (including 
symptoms and fall in blood pressure) (16). Furthermore 
a reduced exercise tolerance and more adverse ventricular 
remodelling, rather than valve obstruction, predicted 
unplanned hospitalisation, whereas the only difference 
between those who went for surgery was a higher mean 
PG suggesting that clinicians may be more influenced 
by conventional measures of aortic valve obstruction. 
Supporting the hypothesis that ventricular response is 
at least as important as valvular obstruction. Exercise 
tolerance in this population was poorly correlated with 
conventional clinical measures of aortic valve severity, 
even under circumstances of flow augmentation, but was 
heavily dependent on the ability of the LV to augment 
longitudinal function during exercise. Furthermore, a 
similar inverse relationship with NT-ProBNP was observed 
for exercise S′, whereas other parameters of LV function or 
valve obstruction were not related.
The severity of AS and the LV response to 
chronic pressure afterload resulting in myocardial 
hypertrophy and fibrosis contribute to the progression 
to the point where patients develop symptoms, adverse 
events and therefore require surgery (1, 17, 18). 
Figure 1
Regression analyses with confidence intervals for 
(A) VO2peak and exercise S′; (B) VO2peak and AVA; 
(C) Vo2peak and exercise mean PG; (D) log 
NT-ProBNP and exercise S′; (E) log NT-ProBNP and 
AVA; (F) log NT-ProBNP and exercise mean PG.
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Increased hypertrophy leads to impaired LV relaxation, 
reduced LV compliance and greater metabolic demands 
(19), and this has been associated with the progression of 
heart failure (20). However, the extent of LV hypertrophy 
only weakly correlates with the severity of AS (21, 
22, 23). Focal scar burden within the myocardium is 
strongly correlated with outcome following aortic valve 
replacement (AVR) and prognosis (23, 24), suggesting that 
ventricular response to afterload results in irreversible 
cellular myocardial changes which modulate outcome. 
LVEF is the standard parameter used for assessing global 
systolic dysfunction and a current indicator for aortic valve 
intervention (4, 16). LVEF reduction, used in isolation, 
is unsatisfactory as in this circumstance reduction is a 
late manifestation of ventricular decompensation and 
myocardial fibrosis (25, 26). Furthermore, in AS, it is 
common to overestimate systolic function for simple 
geometric reasons, as ventricular volumes are reduced 
due to concentric hypertrophy (27), leading to a small 
stroke volume for a given LVEF. As our current model of 
systolic function is clearly incomplete, more subtle and 
predictive parameters to describe ventricular performance 
are required.
Longitudinal systolic function is more sensitive 
in detecting early myocardial dysfunction (28). When 
assessed by strain rate imaging (27, 29, 30), it predicts 
adverse event more accurately (31) than LVEF in patients 
with AS. A recent meta-analysis demonstrated that in 
asymptomatic patients with severe AS and normal LVEF, 
impaired global longitudinal strain is associated with 
reduced survival (32). Lancellotti et  al. included 126 
asymptomatic patients with severe AS and found that 
patients with impaired longitudinal function have a 
greater risk of developing cardiac events (19). Annular or 
myocardial longitudinal velocity are an alternative, well-
established method of quantifying longitudinal systolic 
function (33, 34). Although unlike 2D strain imaging, 
TVI is angle dependent, but it has the advantage of 
being much less dependent on overall 2D image quality 
making it useful in most patients and during stress 
echocardiography. Alternative means of estimating LV 
dysfunction is the use of systemic biomarkers. Significant 
associations have been found between NT-ProBNP and 
myocardial longitudinal contractility and the degree 
of symptoms in asymptomatic patients with severe AS 
(36). Rajani and colleagues included 38 patients with 
moderate and severe AS and found that blood BNP levels 
strongly predicted patients who became symptomatic 
during exercise (37). NT-ProBNP is able to unmask early 
ventricular decompensation; however, the influence of 
age and sex and the threshold used to determine adverse 
events differ greatly between studies. Guidelines including 
reference values should be established to implement the 
use of NT-ProBNP in a clinical setting in patients with 
severe AS.
In this study, confirming the results of many others, 
the standard clinical markers of AS severity correlated very 
poorly with predicted exercise limitation or outcomes. The 
only resting parameter which was associated with exercise 
tolerance was the mean PG; however, this was only a 
weak relationship. The poor correlation between resting 
echo findings and objective exercise limitation has been 
previously demonstrated in the literature (10, 11). Exercise 
parameters, which do seem to predict prognosis in some 
studies, have not previously predicted exercise tolerance 
(10). As far as we are aware, no previous evaluations to 
date have investigated longitudinal velocity in relation to 
CPET at exercise.
This paper clearly demonstrates a relationship 
between longitudinal velocity and VO2peak, not explained 
by other clinical parameters. The results are considerably 
Table 2 Correlation (Spearman’s) between VO2 peak and 
echocardiographic parameters at rest and exercise (latest visit).
VO2 peak (mL/kg/min)
Demographics
 Age (years) −0.76*
 Weight (kg) 0.19
 Height (m) 0.45*
Resting parameters
 S′ rest (cm/s) 0.16
 LVEF rest (%) −0.17
 RWT −0.21
 Rest max V (cm/s) 0.42§
 Rest mean PG (mmHg) 0.40§
 Rest SV 0.26
 Rest AVA (cm2) 0.21
 Rest AVAi (cm2/m2) −0.19
 Dimensionless index −0.14
Exercise parameters
 S′ exercise (cm/s) 0.57*
 LVEF exercise (%) 0.25
 Exercise max V (cm/s) 0.39§
 Exercise mean PG (mmHg) 0.43§
 SV exercise 0.25
 Exercise AVA (cm2) 0.28
 ∆S′ from rest to exercise 0.44§
 ∆ mean PG from rest to exercise 0.16
 ∆ SV from rest to exercise −0.05
*P < 0.001; §P < 0.05.
AVA, aortic valve area; AVAi, aortic valve area indexed; LVEF, left 
ventricular ejection fraction; mean PG, mean pressure gradient; S′, 
systolic longitudinal velocity measured by tissue velocity imaging; SV, 
stroke volume; Vmax, peak velocity through the aortic valve; VO2peak, 
peak oxygen consumption.
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more plausible because of the co-existing inverse, and is 
among other measured parameters a unique, relationship 
with log NT-ProBNP, thus suggesting that patients with 
lower longitudinal systolic reserve have on average, higher 
intracardiac pressures. We have previously documented 
the importance of systolic velocity reserve in a variety of 
different clinical conditions (38, 39) and its importance 
seems to be confirmed here in patients with AS.
Both stress echocardiography and CPET have 
been used to establish the likelihood of future cardiac 
events. Exercise echocardiography provides additional 
information including the haemodynamic changes 
that occur during exercise. An increase in mean PG 
of 18 mmHg or more on exercise is an independent 
predictor for death and hospital admissions (36). A 
study by Maréchaux et al., included 186 asymptomatic 
patients with at least moderate AS (mean PG >35 mmHg) 
and preserved LV function (40). A nine-fold increase in 
event rate (AVR or death) was found in patients with 
an increase in mean PG of more than 20 mmHg on 
exercise; the increase in gradient could not be predicted 
from resting clinical or echocardiographic data. In our 
cohort, eight patients demonstrated an increase in 
gradient of more than 20 mmHg. Three of these eight 
patients were referred for AVR. However, this was not 
associated with cardiac hospitalisation or referral for 
AVR and is probably due to the small numbers with a 
high gradient on exercise. Resting mean PG was higher 
for patients referred for AVR compared to those who 
were not suggesting that clinicians are more influenced 
by conventional measures of aortic valve obstruction. 
Our study suggests that exercise performance from CPET 
is the strongest predictor of cardiac hospitalisation. The 
parameter investigated was % predicted VO2peak but 
not VO2peak, this is a surprising finding, and probably 
because % predicted VO2peak is indexed for normative 
values (height, weight, age included). Indexing VO2peak 
provides the ability to compare patients with different 
ages, weights and heights. However, normative values 
for S′ are currently unknown, and needed to be able 
to undertake comparable analyses. A recent study by 
Domanski and colleagues found that a VO2peak of 
less than 85% was a predicted value associated with 
lower event-free survival in 51 asymptomatic patients 
Figure 2
ROC curve for hospitalisation. % predicted VO2 has the largest area under 
curve r2 = 0.76 (95% CI: 0.57–0.96).
Table 3 Correlation (Spearman’s) between NT-ProBNP and 
echocardiographic parameters at rest and exercise (latest visit).
Log NT-ProBNP
Demographics
 Age (years) 0.55*
 Weight (kg) 0.23
 Height (m) −0.31
Resting parameters
 S′ rest (cm/s) −0.30
 LVEF rest (%) −0.06
 Rest max V (cm/s) −0.23
 Rest mean PG (mmHg) 0.28
 Rest SV −0.06
 Rest AVA (cm2) −0.01
 Rest AVAi (cm2/m2) 0.14
 Dimensionless index 0.02
Exercise echocardiography parameters
 S′ exercise (cm/s) −0.75*
 LVEF exercise (%) −0.46
 Exercise max V (cm/s) −0.32
 Exercise mean PG (mmHg) −0.35
 Exercise SV −0.44§
 Exercise AVA (cm2) −0.31
 ∆S′ from rest to exercise −0.58*
 ∆ mean PG from rest to exercise 0.22
 ∆ SV from rest to exercise −0.33
Cardiopulmonary exercise testing parameters
 VO2 peak (mL/kg/min) −0.51*
 OUES ((mL/min)/(L/min)) −0.46§
 VE/VCO2 slope 0.34
*P < 0.001; §P < 0.05.
BSA, body surface area; NT-ProBNP, brain natriuretic peptide; LVEF, left 
ventricular ejection fraction; S′, systolic longitudinal velocity measured by 
tissue velocity imaging; Vmax, peak velocity through the aortic valve; mean 
PG, mean pressure gradient; AVA, aortic valve area; AVAi, aortic valve area 
indexed; VO2peak, peak oxygen consumption; OUES, oxygen uptake 
efficiency slope.
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with severe AS (10). Our data agree with this finding. 
In the Domanski paper, no parameters obtained during 
stress echocardiography were able to predict events 
concluding that CPET should be incorporated when 
patients are placed in the watchful waiting category. 
However, authors did not include any parameters 
describing longitudinal function during exercise in the 
analyses. Longitudinal function has previously shown 
good prognostic power for future events (38).
Limitations
The study was retrospective and based around protocolled 
clinical evaluation. Strain analysis either by TVI or by 
speckle tracking was not used in this study, and this 
might have provided further insights into global and 
regional deformation. However the major benefit of S′ 
is the simplicity and high reproducibility. Furthermore, 
a recumbent cycle ergometer was used instead of the 
traditional upright cycle ergometer. The use of the 
recumbent cycle ergometer is necessary in order to obtain 
exercise echocardiographic parameters of good quality. 
A small unpublished study found a good relationship 
and reasonable agreement between the upright and the 
semi-recumbent cycle ergometers. And finally the clinical 
decision to refer to surgery was carried out by a consultant 
cardiologist who had all information available (stress 
echocardiographic, CPET and NT-ProBNP parameters) but 
might have been biased, we were unable to determine 
which parameter was used in the decision to send patients 
for surgical intervention.
Conclusion
A large percentage of patients with supposedly 
asymptomatic severe AS with normal ejection fraction 
have a lower than predicted VO2. This is more dependent 
upon the ability of the LV to augment longitudinal 
function on exercise than the level of obstruction at the 
aortic valve (either at rest or with augmented flow) or the 
resting structural remodelling of the LV. Exercise S′ was 
not only independently associated with VO2peak but also 
NT-ProBNP which further confirms that the relationship is 
stronger than conventional AS severity and LV remodelling 
parameters. The burden of unplanned hospitalisation was 
high, and this was predictable when patients had lower 
than predicted VO2peak. More patients were unmasked as 
having abnormal exercise performance using CPET than 
conventional exercise parameters advocated in current 
guidelines. This suggests that where watchful waiting 
is an agreed strategy, a detailed assessment should be 
undertaken including CPET, exercise echocardiography 
and biomarkers to ensure those with exercise limitation 
and risk of decompensation are detected early and 
treated appropriately. The combination of exercise 
echocardiography and CPET in this setting can therefore 
unmask patients with exercise limitation and subtle 
changes in LV performance not identified by current 
treadmill based guidelines as well as demonstrating, but 
still predict adverse cardiac events.
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